RWJ-333369 (Carsibamate)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for RWJ-333369 (Carsibamate), covering 2018-05-01 to 2018-05-01. Get the full timeline:
Most recent: Clinical Trial Update: Study for Safety and Effectiveness of RWJ-333369 (Carsibamate) for the Treatment of Diabetic Peripheral Neuropathy (DPN). [Phase 2]